We explored the rationale for peripheral blood NLR as a surrogate biomarker for prognosis based on its association with CD3+, CD8+ and FOXP3+ TILs in resected NSCLC tissue specimens. This evidence concerns the gene FOXP3 and non-small cell lung carcinoma.